Edition:
United Kingdom

Arsanis Inc (ASNS.OQ)

ASNS.OQ on NASDAQ Stock Exchange Global Market

13.64USD
8:59pm GMT
Change (% chg)

$-0.21 (-1.52%)
Prev Close
$13.85
Open
$13.90
Day's High
$14.05
Day's Low
$13.64
Volume
5,354
Avg. Vol
--
52-wk High
$19.28
52-wk Low
$10.50

Chart for

About

Arsanis, Inc. is a biopharmaceutical company. The Company is focused on the discovering and developing monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Arsanis Inc Files To Say It Has Raised $20 Million In Equity Financing - SEC Filing

* ARSANIS INC FILES TO SAY IT HAS RAISED $20 MILLION IN EQUITY FINANCING - SEC FILING Source text (http://bit.ly/2AvvJ48) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

04 Dec 2017

BRIEF-New Enterprise Associates 16 L.P. Reports 14.6 Percent Stake In Arsanis As Of Nov 20

* NEW ENTERPRISE ASSOCIATES 16 L.P. REPORTS A 14.6 PERCENT STAKE IN ARSANIS AS OF NOVEMBER 20, 2017 - SEC FILING Source text : [ID:http://bit.ly/2ncluP0] Further company coverage:

29 Nov 2017

Earnings vs. Estimates